Crinetics Pharmaceuticals (CRNX) Other Accumulated Expenses (2017 - 2025)

Crinetics Pharmaceuticals' Other Accumulated Expenses history runs 9 years deep, the most recent figure standing at $1.8 million for Q2 2025.

• In Q2 2025, Other Accumulated Expenses rose 66.42% year-over-year to $1.8 million; the TTM figure through Jun 2025 stood at $1.8 million (up 66.42% YoY), while the FY2024 annual figure was $901000.0, down 72.42% from the prior year.
• Other Accumulated Expenses was $1.8 million for Q2 2025 at Crinetics Pharmaceuticals, up from $1.7 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $3.3 million in Q4 2023 to a low of $335000.0 in Q4 2022.
• Historically, Other Accumulated Expenses has averaged $1.1 million across 5 years, with a median of $925500.0 in 2021.
• The sharpest annual moves came in 2023 and 2024: Other Accumulated Expenses surged 875.22% in 2023, then sank 72.42% in 2024.
• A 5-year view of Other Accumulated Expenses shows it stood at $939000.0 in 2021, then plunged by 64.32% to $335000.0 in 2022, then soared by 875.22% to $3.3 million in 2023, then tumbled by 72.42% to $901000.0 in 2024, then jumped by 99.67% to $1.8 million in 2025.
• The last three Other Accumulated Expenses figures came in at $1.8 million (Q2 2025), $1.7 million (Q1 2025), and $901000.0 (Q4 2024), per Business Quant data.